Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
In 2022, JW Pharmaceutical generated over 53 percent of its sales revenue by selling to general hospitals. A further roughly 38 percent of its wholesale sales were to pharmacies.
Sales revenue distribution of JW Pharmaceutical Corporation in South Korea as of December 2022, by channel
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Italy: pharmaceutical marketing channels according to GPs
- Premium Statistic Italy: pharmaceutical marketing channels according to Medical Specialists 2017
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Basic Statistic Trade balance in high technology sectors of EU countries 2022
- Premium Statistic Sales volume of the pharmaceutical market in Italy 2014-2022, by product
About the region
10
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2022
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
Selected statistics
7
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Premium Statistic Pfizer's ad spending 2006-2023
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Basic Statistic Largest nonprescription pharmaceutical companies in Norway 2021, by market share
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Basic Statistic Members of EFPIA's pharmaceutical production value 1990-2022
- Basic Statistic Annual investment of Alliance Pharma through acquisitions 2004-2022
- Basic Statistic Percentage of active U.S. drug shortages in top therapeutic classes June 2023
- Premium Statistic Revenue of pharmacies in Italy 2020, by category
- Premium Statistic Industry turnover for leading pharmaceuticals German 2017
- Basic Statistic Usage rate of top drug classes prescribed to seniors in Canada by age 2021
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
Related statistics
10
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
- Premium Statistic Yuhan-Kimberly's sales revenue 2016-2019
- Premium Statistic Anti-cancer drugs estimated market size in South Korea 2014-2020
Further related statistics
10
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
DART. (March 21, 2023). Sales revenue distribution of JW Pharmaceutical Corporation in South Korea as of December 2022, by channel [Graph]. In Statista. Retrieved May 04, 2024, from https://www.statista.com/statistics/781137/south-korea-jw-pharmaceutical-sales-distribution-by-channel/
DART. "Sales revenue distribution of JW Pharmaceutical Corporation in South Korea as of December 2022, by channel." Chart. March 21, 2023. Statista. Accessed May 04, 2024. https://www.statista.com/statistics/781137/south-korea-jw-pharmaceutical-sales-distribution-by-channel/
DART. (2023). Sales revenue distribution of JW Pharmaceutical Corporation in South Korea as of December 2022, by channel. Statista. Statista Inc.. Accessed: May 04, 2024. https://www.statista.com/statistics/781137/south-korea-jw-pharmaceutical-sales-distribution-by-channel/
DART. "Sales Revenue Distribution of Jw Pharmaceutical Corporation in South Korea as of December 2022, by Channel." Statista, Statista Inc., 21 Mar 2023, https://www.statista.com/statistics/781137/south-korea-jw-pharmaceutical-sales-distribution-by-channel/
DART, Sales revenue distribution of JW Pharmaceutical Corporation in South Korea as of December 2022, by channel Statista, https://www.statista.com/statistics/781137/south-korea-jw-pharmaceutical-sales-distribution-by-channel/ (last visited May 04, 2024)
Sales revenue distribution of JW Pharmaceutical Corporation in South Korea as of December 2022, by channel [Graph], DART, March 21, 2023. [Online]. Available: https://www.statista.com/statistics/781137/south-korea-jw-pharmaceutical-sales-distribution-by-channel/